Detrimental effects of dual ACEI-ARB therapy: Is the (pro)renin receptor the culprit

Kidney International

Volumn 80, Issue 9, 2011, Pages 911-914

  Elijovich, Fernando ^a   Laffer, Cheryl L ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALISKIREN; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PRORENIN; PRORENIN RECEPTOR; RENIN; RENIN INHIBITOR;

ATHEROSCLEROSIS; CLINICAL TRIAL (TOPIC); DIABETIC NEPHROPATHY; DRUG FATALITY; ENZYME ACTIVATION; GLOMERULOPATHY; HEART FAILURE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; KIDNEY FAILURE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENIN RELEASE; RETROSPECTIVE STUDY; REVIEW; SAMPLE SIZE; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

EID: 80054769791     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.264     Document Type: Note

References (10)

1. Chan KE , Ikizler TA , Gamboa JL e t al. Combination angiotensin- converting enzyme inhibition and receptor blockade associate with increased risk of cardiovascular death in hemodialysis patients . Kidney Int 2011; 8 0: 9 78- 9 85.
2. Huang Y, Noble NA, Zhang J e t al. Renin-stimulated TGF-β 1 expression is regulated by a mitogenactivated protein kinase in mesangial cells . Kidney Int 2007; 7 2: 4 5- 5 2.
3. Saris JJ, t Hoen PAC, Garrelds IM e t al. Prorenin induces intracellular signaling in cardiomyocytes independently of angiotensin II . Hypertension 2006; 4 8: 5 64- 5 71.
4. Schefe JH , Menk M , Reinemund J et al. A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein . Circ Res 2006; 9 9: 1 355- 1 366.
5. Parving HH, Persson F, Lewis JB e t al. Aliskiren combined with losartan in type 2 diabetes and nephropathy. N Engl J Med 2008; 3 58: 2433-2446 .
6. Feldman DL, Jin L, Xuan H e t al. Effects of aliskiren on blood pressure, albuminuria, and (pro)rennin receptor expression in diabetic TG(mRen-2)27 rats Hypertension 2008; 5 2: 1 30- 1 36.
7. Parving HH, Brenner BM, McMurray JJV e t al. Aliskiren Trial in Type 2 Diabetes Using Cardio- Renal Endpoints (ALTITUDE): rationale and study design. N ephrol Dial Transplant 2009; 2 4: 1663-1671 .
8. Reudelhuber TL . Prorenin, renin, and their receptor: moving targets . H ypertension 2010; 5 5: 1071-1074 .
9. van Esch JHM , van Veghel R , Garrelds IM e t al. Handle region peptide counteracts the beneficial effects of the renin inhibitor aliskiren in spontaneously hypertensive rats . Hypertension 2011; 5 7: 8 52- 8 58.
10. Funke-Kaiser H , Zollmann FS , Schefe JH e t al. Signal transduction of the (pro)renin receptor as a novel therapeutic target for preventing endorgan damage . H ypertens Res 2010; 3 3: 9 8- 1 04.